Researchers from the University College London’s School of Pharmacy have concluded that 3D Printers using Stereolithography (SLA) technology are most viable and potent for manufacturing oral tablets for prescription drugs. This will allow them to keep the drugs contained with the “solidified matrices” thus reducing degradation and enhancing drug action.